Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pierce

Showing results (691-700 of 808) with videos related to

Pageof 81
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric techniqueR A Pierce, E D Field, J M den Haan, et al.
American Journal of Human Genetics|February 25, 2014
Exome-based mapping and variant prioritization for inherited Mendelian disordersDaniel C Koboldt, David E Larson, Lori S Sullivan, et al.
Trials|May 19, 2010
The Chest Pain Choice trial: a pilot randomized trial of a decision aid for patients with chest pain in the emergency departmentMeghan A Pierce, Erik P Hess, Jeffrey A Kline, et al.
Investigative Ophthalmology & Visual Science|September 24, 2010
Identification of disease-causing mutations in autosomal dominant retinitis pigmentosa (adRP) using next-generation DNA sequencingSara J Bowne, Lori S Sullivan, Daniel C Koboldt, et al.
Blood|March 29, 2003
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoproteinEric Spierings, Anthony G Brickner, Jennifer A Caldwell, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 14, 2004
Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung diseaseDonald C McCurnin, Richard A Pierce, Ling Yi Chang, et al.
Ejhaem|July 18, 2022
A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYALale Kostakoglu, Federico Dalmasso, Paola Berchialla, et al.
Investigative Ophthalmology & Visual Science|October 23, 2018
Clinical Features of a Retinopathy Associated With a Dominant Allele of the RGR GeneRola Ba-Abbad, Monique Leys, Xinjing Wang, et al.
International Journal of Hematology|March 5, 2019
Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitorsKoji Sasaki, Hagop M Kantarjian, Susan O'Brien, et al.
Plos One|February 8, 2018
The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort studyDelphine L Chen, Howard J Huang, Derek E Byers, et al.
Pageof 81

Showing results (691-700 of 808) with videos related to

Sort By:
Pageof 81
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric techniqueR A Pierce, E D Field, J M den Haan, et al.
American Journal of Human Genetics|February 25, 2014
Exome-based mapping and variant prioritization for inherited Mendelian disordersDaniel C Koboldt, David E Larson, Lori S Sullivan, et al.
Trials|May 19, 2010
The Chest Pain Choice trial: a pilot randomized trial of a decision aid for patients with chest pain in the emergency departmentMeghan A Pierce, Erik P Hess, Jeffrey A Kline, et al.
Investigative Ophthalmology & Visual Science|September 24, 2010
Identification of disease-causing mutations in autosomal dominant retinitis pigmentosa (adRP) using next-generation DNA sequencingSara J Bowne, Lori S Sullivan, Daniel C Koboldt, et al.
Blood|March 29, 2003
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoproteinEric Spierings, Anthony G Brickner, Jennifer A Caldwell, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 14, 2004
Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung diseaseDonald C McCurnin, Richard A Pierce, Ling Yi Chang, et al.
Ejhaem|July 18, 2022
A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYALale Kostakoglu, Federico Dalmasso, Paola Berchialla, et al.
Investigative Ophthalmology & Visual Science|October 23, 2018
Clinical Features of a Retinopathy Associated With a Dominant Allele of the RGR GeneRola Ba-Abbad, Monique Leys, Xinjing Wang, et al.
International Journal of Hematology|March 5, 2019
Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitorsKoji Sasaki, Hagop M Kantarjian, Susan O'Brien, et al.
Plos One|February 8, 2018
The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort studyDelphine L Chen, Howard J Huang, Derek E Byers, et al.
Pageof 81